DoctorElla Smalley

Postdoctoral Research Fellow

Menzies Institute for Medical Research

  • Postdoctoral Research Fellow
    Menzies Institute for Medical Research

FUNDED PROJECTS

  • GRANT
    The Macrophage/Alveolar Type 2 cell axis and Dysfunction Driven by Telomere Biology Gene Variants in Pulmonary Fibrosis
    1 Jan 2027 - 31 Dec 2027
    People funded by this grant:
    • Dickinson J,
    • Smalley E,
    • Raspin K,
    • Allen P,
    • Werder R
    Project Total: $200,000; The goal of this project is to define how inherited telomere-related genetic drivers of pulmonary fibrosis disrupt normal macrophage function and perpetuate inflammatory processes. Further, we will examine how this dysfunction contributes to exacerbations for those with telomere-related pulmonary fibrosis. Funded by: Centre for Research Excellence in Pulmonary Fibrosis - Grant-Kickstarter Application ($200,000); University of Tasmania.
  • GRANT
    A novel iPSC-derived organoid and co-culture model to investigate genetic drivers and therapeutic targets in familial pulmonary fibrosis
    1 Jul 2026 - 1 Jul 2027
    People funded by this grant:
    • Smalley E,
    • Dickinson J
    Project Total: $75,000; This fellowship will focus on optimizing a pipeline for directly testing the impact of the genes and gene variants identified through the Genetic Research in Pulmonary Fibrosis (GRIPF) study. The GRIPF study is focused on collecting information and blood samples from individuals with a family history of PF, and through sequencing their whole genome is looking for variants that may be causing disease. These genetic factors can combine with environmental insults such as cigarette smoke, air pollutants/occupational dusts and viral infections to drive disease progression and testing the impact of these variants in respect to occupational dusts and cigarette smoke exposure will allow us to thoroughly investigate the gene-environmental interactions that are occurring in real life PF patients. Funded by: Lung Foundation Australia - CREATE Hope Fellowship in Pulmonary Fibrosis (PF) Research ($75,000); University of Tasmania.
  • GRANT
    Characterising Rare Prostate Cancer Risk Variants using a Prostate Organoid Model
    Cancer Council of Tasmania1 Mar 2026 - 28 Feb 2027
    People funded by this grant:
    • FitzGerald L,
    • Raspin K,
    • Smalley E,
    • Dickinson J
    Project Total: $30,000; Prostate organoids provide significant potential to investigate the function of genetic mutations in a model that closely mimics the normal human prostate. However, given the recent development of the prostate organoid methodology, this has not yet been explored. Earlier this year, we received funding from Tuxedo Junction (via Cancer Council Tasmania) to establish the prostate organoid methodology in our laboratory. This work is currently ongoing in collaboration with the Murdoch Childrens Research Institute (see Preliminary Data section below) and will result in a model that mimics the normal prostate environment. Here, we request funding to introduce a prostate cancer risk mutation into the iPSCs, so we can determine its functional impact on normal prostate cells and how it leads to prostate cancer development. Funded by: Cancer Council of Tasmania - Grant - Small Grant Program ($30,000); University of Tasmania.
  • GRANT
    The Genetics Research in Pulmonary Fibrosis Study
    1 Jan 2026 - 31 Dec 2027
    People funded by this grant:
    • Dickinson J,
    • Lucas S,
    • Raspin K,
    • Smalley E
    Project Total: $600,000; The objective of this study is to define the inherited causes of pulmonary fibrosis. This is follow-up research to the current GRIPF project, which is identifying rare, high risk. familial IPF genes and the functional evaluation of those variants in an iPSC-stem cell derived model of the lung. Funded by: Donation via Menzies Institute for Medical Research - Donation ($600,000); University of Tasmania.
  • GRANT
    Establishing the Pulmonary Fibrosis Variant Curation Database
    1 Jan 2025 - 31 Dec 2025
    People funded by this grant:
    • Lucas S,
    • Dickinson J,
    • Raspin K,
    • Cristian Stanel S,
    • Corte T
    Project Total: $29,994; Establish an international variant curation database to capture rare variants identified in ILD patients through both research and clinical genetic testing, integrated with clinical data, to expedite targeted ILD genetic research the identification of ILD-causing variants. Funded by: Pulmonary Fibrosis Australasian Clinical Trials (PACT) Network - Grant - Grant-in-Aid ($29,994); University of Tasmania ($41,643).
  • GRANT
    The Genetics Research in Pulmonary Fibrosis Study 2024-2025
    1 Aug 2024 - 31 Dec 2028
    People funded by this grant:
    • Dickinson J,
    • Lucas S,
    • Raspin K,
    • Smalley E
    Project Total: $640,000; The objective of this study is to define the inherited causes of pulmonary fibrosis. This is follow-up research to the current GRIPF project, which is identifying rare, high risk, familial IPF genes. Funded by: Donation via Menzies Institute for Medical Research - Donation ($640,000); University of Tasmania ($151,199).
  • GRANT
    Establishing the Interstitial Lung Disease (ILD) Variant Curation Database
    1 Jul 2024 - 31 Mar 2026
    People funded by this grant:
    • Lucas S,
    • Dickinson J,
    • Raspin K,
    • Cristian Stanel S,
    • Corte T
    Project Total: $100,000; Establish an international variant curation database to capture rare variants identified in ILD patients through both research and clinical genetic testing, integrated with clinical data, to expedite targeted ILD genetic research the identification of ILD-causing variants. Funded by: Centre for Research Excellence in Pulmonary Fibrosis - Grant-Kickstarter Application ($39,902); University of Tasmania.